Extracellular self-assembly of virus-like particles from secreted recombinant polyoma virus major coat protein

被引:4
作者
Ng, J. [1 ]
Koechlin, O. [1 ]
Ramalho, M. [1 ]
Raman, D. [1 ]
Krauzewicz, N. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, London W12 0NN, England
基金
英国医学研究理事会;
关键词
gene therapy; polyomavirus; virus-like particles; VP1;
D O I
10.1093/protein/gzm062
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mouse polyoma virus major coat protein (VP1) expressed from a recombinant baculovirus is efficiently transported to infected cell nuclei and assembles into protein nanospheres morphologically similar to natural capsids. The nanospheres readily combine with plasmid DNA to form a hybrid gene therapy agent known as virus-like particles (VLPs). To facilitate large-scale production of VLPs free from cellular contaminants, the use of stable Drosophila cell lines expressing either wild-type protein, or VP1 tagged with a secretion signal for targeting to the extracellular medium, was investigated. Both wild-type and tagged VP1 expressed at 2-4 mg VP1/litre of culture. As expected, the wild-type protein self-assembled into VLPs. The tagged VP1 was efficiently secreted to the extracellular medium but was also glycosylated, unlike wild-type VP1. Despite this fact, a small fraction of the recombinant secreted protein assembled into VLP-like structures that had altered disulphide bonding, but were still biologically active. These results demonstrate the considerable tolerance in the nanosphere assembly to structural (i.e. aberrant glycosylation) and environmental (i.e. extracellular medium vs. nuclear milieu) changes. Thus, with modifications to improve nanosphere assembly, the secretion method could be adapted to large-scale preparation of VLPs, providing significant advantages over current methods of production of the vector.
引用
收藏
页码:591 / 598
页数:8
相关论文
共 36 条
[1]   Role for centromeric heterochrornatin and PML nuclear bodies in the cellular response to foreign DNA [J].
Bishop, CL ;
Ramalho, M ;
Nadkarni, N ;
Kong, WM ;
Higgins, CF ;
Krauzewicz, N .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (07) :2583-2594
[2]   DIFFERENCES IN THE SUB-POPULATIONS OF THE STRUCTURAL PROTEINS OF POLYOMA VIRIONS AND CAPSIDS - BIOLOGICAL FUNCTIONS OF THE MULTIPLE VP1 SPECIES [J].
BOLEN, JB ;
ANDERS, DG ;
TREMPY, J ;
CONSIGLI, RA .
JOURNAL OF VIROLOGY, 1981, 37 (01) :80-91
[3]   CHARACTERIZATION AND USE OF THE DROSOPHILA METALLOTHIONEIN PROMOTER IN CULTURED DROSOPHILA-MELANOGASTER CELLS [J].
BUNCH, TA ;
GRINBLAT, Y ;
GOLDSTEIN, LSB .
NUCLEIC ACIDS RESEARCH, 1988, 16 (03) :1043-1061
[4]   Methylation of the polyomavirus major capsid protein VP1 [J].
Burton, KS ;
Consigli, RA .
VIRUS RESEARCH, 1996, 40 (02) :141-147
[5]   THE USE OF ADDITIVE AND SUBTRACTIVE APPROACHES TO EXAMINE THE NUCLEAR-LOCALIZATION SEQUENCE OF THE POLYOMAVIRUS MAJOR CAPSID PROTEIN-VP1 [J].
CHANG, DC ;
HAYNES, JI ;
BRADY, JN ;
CONSIGLI, RA .
VIROLOGY, 1992, 189 (02) :821-827
[6]   Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions from chelation [J].
Chen, PL ;
Wang, ML ;
Ou, WC ;
Lii, CK ;
Chen, LS ;
Chang, DC .
FEBS LETTERS, 2001, 500 (03) :109-113
[7]  
FORSTOVA J, 1993, J VIROL, V67, P1405
[8]   POLYOMA-VIRUS PSEUDOCAPSIDS AS EFFICIENT CARRIERS OF HETEROLOGOUS DNA INTO MAMMALIAN-CELLS [J].
FORSTOVA, J ;
KRAUZEWICZ, N ;
SANDIG, V ;
ELLIOTT, J ;
PALKOVA, Z ;
STRAUSS, M ;
GRIFFIN, BE .
HUMAN GENE THERAPY, 1995, 6 (03) :297-306
[9]   GENETIC ECONOMY OF POLYOMA-VIRUS - CAPSID PROTEINS ARE CLEAVAGE PRODUCTS OF SAME VIRAL GENE [J].
FRIEDMANN, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (02) :257-259
[10]   Virus-like particles as vaccines and vessels for the delivery of small molecules [J].
Garcea, RL ;
Gissmann, L .
CURRENT OPINION IN BIOTECHNOLOGY, 2004, 15 (06) :513-517